Zdrowie i gospodarka · 05/07/2005
FDA's Cellular, Tissue and Gene Therapies Advisory Committee to Meet on Recent Advances in Therapies
The committee, formerly known as the Biological Response Modifiers Advisory Committee, will discuss recent developments in cellular, tissue, and gene therapies during its upcoming meeting
Source: Federal Register — Food and Drug AdministrationOpen original release →